These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37113501)

  • 1. Beliefs of rheumatologists and general practitioners on urate lowering therapy: a cross-sectional study.
    Veenstra F; Vriezekolk JE; van den Bemt BJF; Schers HJ; Sloot B; van den Ende CHM; van Herwaarden N; Flendrie M
    Rheumatol Adv Pract; 2023; 7(2):rkad033. PubMed ID: 37113501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beliefs about medicines in gout patients: results from the NOR-Gout 2-year study.
    Uhlig T; Karoliussen LF; Sexton J; Kvien TK; Haavardsholm EA; Taylor WJ; Hammer HB
    Scand J Rheumatol; 2023 Nov; 52(6):664-672. PubMed ID: 37395419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared decision-making in gout treatment: a national study of rheumatology provider opinion and practice.
    Singh JA; Richards JS; Chang E; Toupin-April K; Barton JL
    Clin Rheumatol; 2021 Feb; 40(2):693-700. PubMed ID: 32997317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of gout by Moroccan rheumatologists: a Moroccan Society for Rheumatology National Survey.
    Moulay Berkchi J; Rkain H; Benbrahim L; Aktaou S; Lazrak N; Faiz S; Ahid S; Abouqal R; Labzizi S; Ouzeddoun N; Oukerraj L; Hmamouchi I; Hajjaj-Hassouni N; Allali F
    Rheumatol Int; 2020 Sep; 40(9):1399-1408. PubMed ID: 32447422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between healthcare practitioners' beliefs about statins and patients' beliefs and adherence.
    Huiskes VJB; van den Ende CHM; van Dijk L; Burger DM; van den Bemt BJF
    Br J Clin Pharmacol; 2021 Mar; 87(3):1082-1088. PubMed ID: 32652589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy.
    Pascart T; Latourte A; Flipo RM; Chalès G; Coblentz-Baumann L; Cohen-Solal A; Ea HK; Grichy J; Letavernier E; Lioté F; Ottaviani S; Sigwalt P; Vandecandelaere G; Richette P; Bardin T
    Joint Bone Spine; 2020 Oct; 87(5):395-404. PubMed ID: 32422338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists.
    Vargas-Santos AB; Castelar-Pinheiro Gda R; Coutinho ES; Schumacher HR; Singh JA; Schlesinger N
    PLoS One; 2015; 10(8):e0135805. PubMed ID: 26274585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout.
    Richardson JC; Liddle J; Mallen CD; Roddy E; Hider S; Prinjha S; Ziebland S
    BMC Musculoskelet Disord; 2016 Jun; 17():249. PubMed ID: 27267878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of gout by UK rheumatologists: a British Society for Rheumatology national audit.
    Roddy E; Packham J; Obrenovic K; Rivett A; Ledingham JM
    Rheumatology (Oxford); 2018 May; 57(5):826-830. PubMed ID: 29447370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of the assessment and management of gout in general practitioners and medical officers within the Illawarra Network, Australia.
    Terrill M; Riordan J
    Int J Rheum Dis; 2017 Aug; 20(8):990-995. PubMed ID: 27153502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical efficacy of urate-lowering therapy in acute gout: a meta-analysis of randomized controlled trials.
    Zhang X; Tang Y; Wang M; Wang D; Li Q
    Clin Rheumatol; 2021 Feb; 40(2):701-710. PubMed ID: 32562072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge and practice in the management of asymptomatic hyperuricemia among primary health care physicians in Jeddah, Western Region of Saudi Arabia.
    Alqarni NA; Hassan AH
    Saudi Med J; 2018 Dec; 39(12):1218-1225. PubMed ID: 30520504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons for discontinuing urate-lowering treatment in community-dwelling adults with gout: results of a primary care-based cross-sectional study.
    Elmelegy D; Abhishek A
    Rheumatol Adv Pract; 2021; 5(2):rkab022. PubMed ID: 34131622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional internet-based patient survey of the management strategies for gout.
    Singh JA; Shah N; Edwards NL
    BMC Complement Altern Med; 2016 Mar; 16():90. PubMed ID: 26931313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China.
    Li QH; Dai L; Li ZX; Liu HJ; Zou CJ; Ou-Yang X; Lu M; Li T; Li YH; Mo YQ; Schumacher HR
    Clin Rheumatol; 2013 Nov; 32(11):1633-40. PubMed ID: 23857664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout.
    Dalbeth N; House ME; Horne A; Petrie KJ; McQueen FM; Taylor WJ
    BMC Musculoskelet Disord; 2012 Sep; 13():174. PubMed ID: 22978848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Care Among Patients With Gout in Europe: A Cross-sectional Survey.
    Te Kampe R; Jansen TL; van Durme C; Janssen M; Petersen G; Boonen A
    J Rheumatol; 2022 Mar; 49(3):312-319. PubMed ID: 34329184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspective of Dutch Patients with Gout on Continuation or Discontinuation of Urate-Lowering Therapy During Remission: A Mixed-Methods Study.
    Peeters IR; Veenstra F; Wanten SAC; Vriezekolk JE; van den Ende CH; den Broeder AA; van Herwaarden N; Verhoef LM; Flendrie M
    Arthritis Care Res (Hoboken); 2024 Jun; ():. PubMed ID: 38924379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician adherence to ACR gout treatment guidelines: perception versus practice.
    Oderda GM; Shiozawa A; Walsh M; Hess K; Brixner DI; Feehan M; Akhras K
    Postgrad Med; 2014 May; 126(3):257-67. PubMed ID: 24918810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urate-lowering therapy adherence and the association with medication beliefs, self-efficacy, depression, anxiety, and COVID-19 pandemic-related concern in Chinese gout patients: a cross-sectional study.
    Yin R; Lu J; Xu Z; Yan Q; Wang M; Xu R
    Psychol Health Med; 2023; 28(7):1698-1708. PubMed ID: 37322811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.